Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer

Ruben T. H. M. Larue*, Remy Klaassen, Arthur Jochems, Ralph T. H. Leijenaar, Maarten C. C. M. Hulshof, Mark I. van Berge Henegouwen, Wendy M. J. Schreurs, Meindert N. Sosef, Wouter van Elmpt, Hanneke W. M. van Laarhoven, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1475-1481
Number of pages7
JournalActa Oncologica
Volume57
Issue number11
DOIs
Publication statusPublished - 2 Nov 2018

Keywords

  • PREOPERATIVE CHEMORADIOTHERAPY
  • NEOADJUVANT CHEMORADIOTHERAPY
  • TUMOR HETEROGENEITY
  • TEXTURAL FEATURES
  • CHEMOTHERAPY
  • REGRESSION
  • STABILITY
  • SIGNATURE
  • CARCINOMA
  • BIOMARKER

Cite this

Larue, R. T. H. M., Klaassen, R., Jochems, A., Leijenaar, R. T. H., Hulshof, M. C. C. M., Henegouwen, M. I. V. B., Schreurs, W. M. J., Sosef, M. N., van Elmpt, W., van Laarhoven, H. W. M., & Lambin, P. (2018). Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer. Acta Oncologica, 57(11), 1475-1481. https://doi.org/10.1080/0284186X.2018.1486039